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Abstract
A metabolic study revealed that 28-norcastasterone in Arabidopsis is synthesized from cholesterol via the late C-6
oxidation pathway. On the other hand, the early C-6 oxidation pathway was found to be interrupted because
cholestanol is converted to 6-oxocholestanol, but further metabolism to 28-norcathasterone was not observed. The
6-oxoBRs were found to have been produced from the respective 6-deoxoBRs administered to the enzyme solution,
thus indicating that these 6-oxoBRs are supplied from the late C-6 oxidation pathway. Heterologously expressed
CYP85A1 and CYP85A2 in yeast catalysed this C-6 oxidation, with CYP85A2 being much more efﬁcient than
CYP85A1. Abnormal growth of det2 and dwf4 was restored via the application of 28-norcastasterone and closer
precursors. Furthermore, det2 and dwf4 could not convert cholesterol to cholestanol and cholestanol to 6-deoxo-28-
norcathasterone, respectively. It is, therefore, most likely that the same enzyme system is operant in the synthesis of
both 28-norcastasterone and castasterone. In the presence of S-adenosyl-L-methionine, the cell-free enzyme extract
catalysed the C-24 methylation of 28-norcastasterone to castasterone, although the conversion rates of 28-
norteasterone to teasterone and 28-nortyphasterol to typhasterol were much lower; this suggests that 28-
norcastasterone is the primary precursor for the generation of C28-BRs from C27-BRs.
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Introduction
The absence of brassinosteroids (BRs) in the Arabidopsis
mutants det2, cpd, and dwf4 (Li et al., 1996; Szekeres et al.,
1996; Choe et al., 1998; Noguchi et al., 1999), tomato dwarf
(Bishop et al., 1999), and pea lkb (Nomura et al., 1997,
1999) results in pleiotropic abnormalities, including reduced
shoot elongation, reduced fertility, delayed senescence, and
altered vasculature and photomorphogenesis. Mutants can
be restored to the wild-type phenotype via the application
of BRs. Similar abnormalities are also observed in the
Arabidopsis mutants bri1 (Li and Chory, 1997), bin2 (Li
et al., 2001; Li and Nam, 2002), and bak1 (Nam and Li,
2002), as well as in the tomato mutant curl-3 (Koka et al.,
2000). However, the mutant phenotype cannot be rescued
by the application of BRs because of disrupted BR signal-
ling. Therefore, BRs are currently regarded as essential
plant hormones whose endogenous levels must be properly
maintained in plant cells to facilitate normal growth and
development.
Naturally-occurring BRs, the number of which totals
over 50, can be classiﬁed into C27-, C28-, or C29-BRs based
on the nature of the alkyl groups occupying the C-24
position in the side chain of the 5a-cholestane carbon
skeleton. Among them, the C28-BRs that harbour a C-24
methyl group are major BRs in the plant kingdom.
Castasterone (CS) and brassinolide (BL) belonging to the
C28-BRs are biologically highly active and, therefore, have
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means of feeding experiments as well as molecular genetics
of BR-deﬁcient mutants. According to the results, two
parallel pathways—namely the early and late C-6-oxidation
pathway in plant cells—have been proposed (Fujioka et al.,
1997; Yokota, 1997; Sakurai, 1999; Bishop and Yokota,
2001; Fujioka and Yokota, 2003; Fig. 1). The biosynthesis
of C28-BRs begins with the hydrogenation of campesterol to
campestanol. In the early C-6 oxidation pathway, campes-
tanol is then oxidized to 6-oxocampestanol, which under-
goes successive oxidation to cathasterone (CT), teasterone
(TE), 3-dehydroteasterone (3-DHT), typhasterol (TY),
and CS. In the late C-6 oxidation pathway, campestanol is
ﬁrst oxidized at C-22 to generate 6-deoxocathasterone
(6-deoxoCT), which is then oxidized successively to
6-deoxoteasterone (6-deoxoTE), 6-deoxo-3-dehydroteaster-
one (6-deoxo-3-DHT), 6-deoxotyphasterol (6-deoxoTY),
6-deoxocastasterone (6-deoxoCS), and CS. Finally, CS is
oxidized to BL with a 7-oxalactone moiety.
28-Norcastasterone (28-norCS), a C27 counterpart of CS,
has also been identiﬁed from as many as 12 plant tissues,
although less frequently than CS (Fujioka, 1999; Fujioka
et al.,2 0 0 0 ; Bajguz and Tretyn, 2003). 28-NorCS possesses
the same carbon skeleton as cholesterol, thus suggesting
that 28-norCS is synthesized from cholesterol in a fashion
similar to the synthesis of CS from campesterol. Tomato
seedlings were determined to contain cholesterol, cholestanol,
and several 6-deoxo-28-norBRs including 6-deoxo-28-
norcathasterone (6-deoxo-28-norCT), 6-deoxo-28-nortyphas-
terol (6-deoxo-28-norTY), and 6-deoxo-28-norcastasterone
(6-deoxo-28-norCS) (Yokota et al., 2001; Kim et al.,2 0 0 4 b).
In addition, the cell-free enzyme extract of tomato seedlings
catalysed the conversion of cholesterol to cholestanol and
6-deoxo-28-norTE to 28-norCS via 6-deoxo-28-nor-3-DHT,
6-deoxo-28-norTY, and 6-deoxo-28-norCS. These ﬁndings
demonstrate that the synthesis of 28-norCS is mediated by
late C-6 oxidation (Kim et al.,2 0 0 4 b). Furthermore, the
cell-free enzyme extract mediated the C-24 methylation of 28-
norCS to CS in the presence of NADPH and S-adenosyl-L-
methionine (SAM). It was also determined that exogenously
applied 28-norCS restores the abnormal growth of the
tomato dwarf mutant which is defective in a cytochrome
Fig. 1. Biosynthetic pathways for C27- and C28-BRs and their connection established in A. thaliana. The solid and dashed arrows
indicate veriﬁed and not veriﬁed biosynthetic steps, respectively. The names on arrows indicate genes or enzymes catalysing biosynthetic
reactions.
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and 6-deoxo-28-norCS to CS and 28-norCS, respectively.
Therefore, 28-norCS is biologically important per se and is
also important in the production of CS.
In Arabidopsis,C 27-BRs including 28-norTY and 28-
norCS have been identiﬁed, in addition to the C28-BRs
(Fujioka et al., 2000). The conversion of cholestanol to
6-oxocholestanol, as a possible upstream step in C27-BRs
biosynthesis, has also been demonstrated (Lee et al., 2010),
although downstream steps for the generation of C27-BRs in
A. thaliana have yet to be clearly elucidated.
Despite our previous efforts, the biosynthesis of C27-BRs
via the early C-6 oxidation pathway remains to be clearly
characterized. Furthermore, the linkage of the early and late
C-6 oxidation pathways of C27-BRs, as well as the bio-
synthetic relationship between C27- and C28-BRs, is still not
completely understood. In this study, these subjects were
investigated using Arabidopsis enzyme extracts. The
enzymes and genes involved in C27-BRs biosynthesis have
also been addressed.
Materials and methods
Plant growth conditions
Cold-treated seeds of wild-type Arabidopsis (Col-0) were planted in
soil and grown for 3 weeks in an environmental growth chamber at
22  C, under a 16 h light (120 lmol photons m
2 s
1)/20  C, 8 h
dark cycle. When seeds were planted on 13 MS medium (Duchefa,
Haarlem, Netherlands) containing 0.8% (w/v) agar and 1% (w/v)
sucrose, the seeds were surface-sterilized with 70% ethanol and
a 30% (v/v) bleach solution containing 0.025% (v/v) Triton X-100.
Enzyme assays
3-week-old soil-grown Arabidopsis plants (20 g) were harvested and
ground with a mortar and pestle in cold 0.1 M sodium phosphate
(pH 7.4) buffer containing 15 mM 2-mercaptoethanol, 1 mM EDTA,
1 mM dithiothreitol, 0.1 mM phenylmethylsulphonyl ﬂuoride,
40 mM ascorbate, 250 mM sucrose, and 10% (v/v) glycerol. The
homogenate was then centrifuged for 15 min at 8000 g to remove cell
debris. The supernatant was then centrifuged for an additional
30 min at 20 000 g. The resultant supernatant was precipitated via
the addition of cold acetone to a ﬁnal concentration of 40% (v/v).
The supernatant–acetone mixture was maintained for 10 min at
–20  C and centrifuged for an additional 10 min at 13 000 g.T h e
resultant precipitate was dissolved in assay buffer containing 0.1 M
sodium phosphate (pH 7.4) containing 1.5 mM 2-mercaptoethanol
and 20% (v/v) glycerol, and used as the cell-free enzyme solution. For
microsomal preparation, the supernatant obtained from centrifuga-
tion at 20 000 g was subjected to 1 h of ultra-centrifugation at
100 000 g. The resultant pellet was re-suspended with assay buffer.
The enzyme assay mixture was composed of 5 lg of substrate,
3–-5 mg of enzyme solution, and the appropriate co-factor
(NADP/NADPH) or co-substrate (S-adenosyl-L-methionine). The
reactions were initiated via the addition of substrate and the
incubation was conducted for 30 min at 37  C. The metabolites of
the enzyme reactions were extracted with ethyl acetate (1.2 ml,
three times) and concentrated in vacuo. The ethyl acetate-soluble
fraction was loaded onto a Sep-Pak C18 cartridge column (Waters,
Milford, MA), and sequentially washed with 50% and 60%
methanol (5 ml each). The fraction eluted with 100% methanol
was concentrated in vacuo, dissolved in 50 ll of methanol, and
then subjected to reversed phase (RP)-HPLC (Senshu Pak C18,
103150 mm) eluted at a ﬂow rate of 2.5 ml min
1 with 100%
methanol for the metabolites of cholesterol and cholestanol or
acetonitrile (MeCN)–water gradients (0–20 min, 45% MeCN;
20–40 min, 45–100% MeCN; 40–70 min, 100% MeCN) for
6-deoxo-28-norBRs, or a ﬂow rate of 2 ml min
1 with 60% MeCN
for 28-norBRs. The fractions were collected every minute. The
fractions (cholestanol, 18–19 min; 6-oxo-cholestanol, 7–8 min;
6-deoxo-28-norCT, 58–61 min; 6-deoxo-28-norTE, 44–46 min;
6-deoxo-28-nor-3-DHT, 46–48 min; 6-deoxo-28-norTY, 49–51
min; 6-deoxo-28-norCS, 36–38 min, 28-norTE, 27–29 min; 28-nor-
3-DHT, 34–36 min; 28-norTY, 33–35 min; 28-norCS, 13–15 min) in
which authentic BRs were detected under the same RP-HPLC
conditions were analysed via GC-MS or GC-SIM after appropriate
derivatization.
C-6 oxidations of C27-and C28-BRs by CYP85A1 and CYP85A2
CYP85A1/V60/WAT21 and CYP85A2/V60/WAT21 yeast strains
were employed as previously described (Kim et al., 2005b).
6-Deoxo-28-norBR and its counterpart, 6-deoxo-BR, (5 lg each)
were fed to galactose-induced yeast cells and incubated for 6 h.
[26,28-
2H6]BR was added to the cell culture as an internal standard
prior to extraction with ethyl acetate. Puriﬁcation using a Sep-Pak
C18 cartridge column was conducted in accordance with the
method described above. The fraction eluted with 100% methanol
was subjected to RP-HPLC (Senshu Pak C18,1 0 3150 mm) eluted
at a ﬂow rate of 2.5 ml min
1 with MeCN–water gradients (0–20
min, 45% MeCN; 20–40 min, 45–100% MeCN; 40–60 min, 100%
MeCN). The fractions (28-norTE, 27–29 min; 28-nor-3-DHT,
34–36 min; 28-norTY, 33–35 min; 28-norCS, 13–15 min; TE,
31–34 min; 3-DHT, 37–39 min; TY, 37–39 min; CS, 19–21 min)
containing C27-BR and C28-BR were eluted and combined, and
then subjected to GC-MS analysis. The quantities of the C28-BRs
metabolites were initially calculated using [26,28-
2H6]BRs as an
internal standard and the amounts of C27-BRs, the counterparts of
C28-BRs, were estimated by the area ratio relative to C28-BRs on
the total ion chromatogram.
Sterol analysis
3-week-old soil-grown Arabidopsis plants (2 g fresh weight) were
harvested and extracted with methanol:chloroform (4:1, v/v). The
extracts were concentrated in vacuo and solvent-partitioned
between chloroform and water. D7 cholesterol (0.5 lg) was added
to the chloroform-soluble fraction as an internal standard. The
fraction extracted with n-hexane after alkaline hydrolysis was
puriﬁed on a Sep-Pak silica cartridge column (Waters, Milford,
MA) and subjected to GC-MS analysis.
GC-MS/SIM analysis
The GC-MS or GC-SIM analyses were conducted as previously
described (Kim et al., 2005b). The samples were subjected to
methaneboronation or trimethylsilyation according to the struc-
tures of the expected metabolites. Methaneboronation was con-
ducted by heating the samples dissolved in pyridine containing
methaneboronic acid (2 mg ml
1)a t8 0 C for 30 min and
N-methyl-N-TMS-triﬂuoroacetamide (MSTFA, Pierce, Rockford,
IL) was used for trimethylsilylation.
Rescue experiments of det2 and dwf4 mutants by C27-BRs
The det2, dwf4, and wild-type (Col-0 or En-2) seeds were surface-
sterilized and planted on 13 MS agar plates containing 1 lMo f
various C27-BR biosynthetic intermediates or mock solution. After
5 d under continuous darkness, the seedlings (n >30) were
photographed with a digital camera and the lengths of the
hypocotyls were measured with Scion Image software (Scion
Corporation, Maryland, USA).
C27-BRs biosynthesis in A. thaliana | 1825Results
Arabidopsis enzymes were extracted with phosphate buffer
containing the appropriate additives prior to centrifugation,
and successive precipitation with acetone. The precipitates
were then dissolved in assay buffers and employed as crude
enzyme extracts for in vitro conversion experiments.
Unlabelled substrates were used for enzymatic incubation,
since isotope-labelled substrates were not available. The
absence of the expected products in the prepared enzyme
extracts was conﬁrmed via GC-MS and GC-SIM prior to
incubation with the substrates. The enzyme products were
puriﬁed via RP-HPLC and then derivatized to trimethylsilyl
ethers (TMSi), bismethaneboronates (BMB) or methanebor-
onate-trimethylsilyl ethers (MB-TMSi). These derivatives
were rigorously characterized by GC-MS and/or GC-SIM
analyses.
Biosynthesis 6-deoxo C27-BRs in A. thaliana
The late C-6 oxidation pathway for 28-norCS proceeds
through the following sequence: cholesterol/cholestanol
/6-deoxo-28-norCT/6-deoxo-28-norTE/6-deoxo-28-nor-
3-DHT/6-deoxo-28-norTY/6-deoxo-28-norCS/28-nor-
CS. The presence of this pathway has been demonstrated,
although not fully clariﬁed, in the tomato. By way of contrast,
no evidence has yet been obtained supporting the existence of
such a pathway in A. thaliana.
Our Arabidopsis enzyme extracts catalysed the conversion
of cholesterol to cholestanol, which is consistent with our
ﬁndings that cholesterol and cholestanol are endogenous in
Arabidopsis plants (Table 1). However, the incubation of
cholestanol and 6-deoxo-28-norCT in the crude Arabidopsis
enzyme extract did not result in any of the expected
metabolites. However, enzymes prepared from microsomes
catalysed the conversion of cholestanol to 6-deoxo-
28-norCT and 6-deoxo-28-norTE (Table 2). The enzymes
that convert cholestanol to 6-deoxo-28-norCT and 6-deoxo-
28-norTE do not appear to be abundant in A. thaliana.O n
the other hand, the crude enzyme extract catalysed
the conversion of 6-deoxo-28-norTE to 6-deoxo-28-nor-3-
DHT and 6-deoxo-28-norTY, of 6-deoxo-28-nor-3-DHT to
6-deoxo-28-norTE and 6-deoxo-28-norTY, and of 6-deoxo-
28-norTY to 6-deoxo-28-nor-3-DHT and 6-deoxo-
28-norTE; these results indicate that the epimerization of
C-3 from 6-deoxo-28-norTE to 6-deoxo-28-norTY occurs
via 6-deoxo-28-nor-3-DHT, in a reversible fashion. The
metabolites of 6-deoxo-28-norTY also included 6-deoxo-
28-norCS, demonstrating that the enzyme extract harbours
C2 a-hydroxylase. Finally, 6-deoxo-28-norCS was metabo-
lized to 28-norCS by the same enzyme extract. It has also
been established that the late C-6 oxidation pathway, which
produces 28-norCS, is operant in A. thaliana, as anticipated.
Biosynthesis of 6-oxo C27-BRs in A. thaliana
If the early C-6-oxidation pathway of C27-BRs exists in
A. thaliana, 28-norCS will be synthesized according to the
following sequence: cholestanol/6-oxocholestanol/28-
norCT/28-norTE/28-nor-3-DHT/28-norTY/28-nor-
CS. It was determined that our Arabidopsis enzyme extracts
catalysed the conversion of cholestanol to 6-oxocholestanol
(Table 2). However, 28-norCT was not detected in the
cholestanol metabolites, and thus this metabolism was
investigated further using enzymes prepared from micro-
somes obtained via ultra-centrifugation. Nonetheless, 28-
norCT, as well as further metabolites including 28-norTE,
were not produced in the reaction mixture as shown by the
results of GC-SIM analysis. It appears most likely that the
pathway from 6-oxocampestanol to 28-norCT is blocked in
Arabidopsis.
The feeding of 28-norTE to the enzyme extract resulted in
the production of 28-nor-3-DHT and 28-norTY, whereas
the feeding of 28-norTY gave rise to 28-nor-3-DHT and 28-
norTE, thereby indicating that 28-norTE and 28-norTY are
interconvertible via 28-nor-3-DHT (Table 2). Furthermore,
28-norCS was identiﬁed as another metabolite of 28-norTY
(Table 2). Therefore, the pathway connecting 28-norTE to
28-noCS was determined to be present in A. thaliana.
Biosynthetic connection of 6-deoxo and 6-oxo C27-BRs
in A. thaliana
Two parallel pathways—the early and late C-6 oxidation
pathways of C28-BRs—are biosynthetically connected by
the C-6 oxidation of 6-deoxoTE, 6-deoxo-3-DHT, and
6-deoxoTY to TE, 3-DHT, and TY, respectively. In
Arabidopsis, AtBR6ox1 (CYP85A1) and AtBR6ox2
(CYP85A2) mediate these C-6 oxidations (Kim et al.,
2005b). An attempt was made to determine whether
CYP85A1 and CYP85A2 are involved in any possible
biosynthetic connection between the early and late C-6
oxidation pathways of C27-BRs. To this end, the cDNA of
Arabidopsis CYP85A1 and CYP85A2 were cloned into
a galactose-inducible expression vector, pYeDP60 (V60),
and transformed into the WAT21 yeast strain, wherein the
expression of Arabidopsis NADPH-Cyt P450 reductase is
inducible by galactose (Pompon et al., 1996; Urban et al.,
1997). After conﬁrming that the C-6 oxidation of 6-deoxo-
28-norCS did not occur in the empty vector-transformed
yeast (V60/WAT21), 6-oxidations of C27- and C28-BRs were
evaluated by the transformed strains (CYP85A1/V60/
WAT21 and CYP85A2/V60/WAT21).
Both CYP85A1/V60/WAT21 and CYP85A2/V60/
WAT21 successfully catalysed the 6-oxidation of C27-BRs,
Table 1. Content of major 4-demethylasterols in A. thaliana
Amount (mgg
1 fresh weight)
1st experiment 2nd experiment
Cholesterol 6.60 7.94
Cholestanol 0.38 1.45
Campesterol 22.41 21.06
Campestanol 1.21 1.02
Stigmasterol 3.62 4.84
Sitosterol 107.13 99.45
Sitostanol 8.35 9.68
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TY, and 6-deoxo-28-norCS to 28-norTE, 28-nor-3-DHT, 28-
norTY, and 28-norCS, respectively (Fig. 2A). The respective
conversion rates were 17, 14, 68, and 24 times higher in
CYP85A2/V60/WAT21 than in CYP85A1/V60/WAT21.
Similarly, when C28-BRs, 6-deoxoTE, 6-deoxo-3-DHT,
6-deoxoTY, and 6-deoxoCS were fed to the transformed
yeast strains, TE, 3-DHT, TY, and CS were detected as the
respective products (Fig. 2B). The rates of conversion by
CYP85A2/V60/WAT21 were also higher than the rates
of conversion by CYP85A1/V60/WAT21, although to lesser
extents than were noted in the 6-oxidations of C27-BRs.
No 6-oxidations occurred in the feedings of the biosynthet-
ically upstream intermediates, campestanol, cholestanol,
6-deoxoCT, and 6-deoxo-28-norCT.
An attempt was also made to determine whether Arabi-
dopsis enzyme extracts are capable of converting 6-deoxo
C27-BRs to 6-oxo C27-BRs. As shown in Table 2, 6-deoxo-
28-norTE, 6-deoxo-28-nor-3-DHT, 6-deoxo-28-norTY, and
6-deoxo-28-norCS were 6-oxidized to 28-norTE, 28-nor-
3-DHT, 28-norTY, and 28-norCS, respectively. However,
the 6-oxidation of 6-deoxo-28-norCT to 28-norCT was not
detected in the enzyme extracts. These ﬁndings are consistent
with those obtained using the transformed yeast strains.
Demethylation of 28-norCS
An attempt was made ﬁrst to characterize the Arabidopsis
enzymatic activity that converts 28-norCS to 28-norBL.
However, we were unable to ﬁnd any such an activity in the
enzyme extract. Rather, it was determined that 28-norCS was
converted to a compound with a molecular ion of m/z 484 as
a BMB derivative. The molecular ion was 14 mass units
smaller than that of the 28-norCS BMB derivative, which
suggests the loss of a methyl group (Table 2). A prominent
ion at m/z 127, which is derived from the side chain due to
the ﬁssion of the C20–C22 bond, is also 14 mass units smaller
than the corresponding ion of 28-norCS BMB. The presence
of ions at m/z 358, 328, and 287 shows the ring structure to
be identical to that of 28-norCS. It is, therefore, likely that
one of the methyls was lost in the side chain. The loss of C-26
has been reported in previous metabolic studies of BRs (Kim
et al.,2 0 0 0 , 2004a). Thus, the most probable structure of this
metabolite is 26,28-dinorCS (Fig. 3).
Conversion of C27-BRs to C28-BRs through C-24
methylation
C27-BRs were incubated with the Arabidopsis enzyme
extracts in the presence of S-adenosyl-L-methionine and
NADPH, and their conversion to C28-BRs was assessed.
The administration of 28-norCS yielded CS, as shown by
a full-scan mass spectrum (Table 2). The administration of
28-norTE, 28-nor-3-DHT, and 28-norTY generated TE,
3-DHT, and TY, respectively, as identiﬁed by GC-SIM.
Their conversion rates ranged from 0.2–0.3%, and were
approximately 20–30-fold lower than that of the C-24
methylation of 28-norCS to CS (Table 3).
Table 2. GC-MS data of metabolites obtained from A. thaliana cell-free conversion experiments
Substrate Metabolite RRt
a Prominent Ions
CHR CHN
b 0.456 460(M+, 54), 445(73), 370(28), 355(43), 305(33), 215(100)
CHN 6-oxoCHN
c 0.495 474 (M+, 19), 459(51), 445(100), 384(4), 159(8)
6-deoxo-28-norCT 0.542 533(M+-15, 1), 368(2), 255(8), 173(100)
6-deoxo-28-norTE 0.605 516(M+, 69), 501(55), 459(23), 426(26), 411(39), 305(35), 230(27), 215(100), 141(30)
28-norTE 28-nor-3-DHT 0.876 456(M+, 90), 399(3), 316(19), 286(13), 245(35), 141(100)
28-norTY 0.735 530(M+, 60), 515(35), 501(100), 440(56), 425(21), 229(16), 141(21)
TE 1.031 544(M+, 29), 529(53), 515(100), 454(5), 300(8), 155(39)
28-nor-3-DHT 3-DHT 1.013 470(M+, 63), 399(7), 357(5), 316(21), 298(10), 287(11), 245(11), 155(100)
28-norTY 28-nor-3-DHT 0.876 456(M+, 90), 399(2), 316(16), 286(11), 245(36), 141(100)
28-norTE 0.906 530(M+, 21), 515(53), 501(100), 440(3), 316(16), 141(11)
28-norCS 0.866 498(M+, 100), 483(8), 399(4), 358(12), 328(7), 287(36), 141(52)
TY 0.863 544(M+, 100), 529(81), 515(55), 454(72), 300(10), 155(60)
28-norCS CS 1.000 512(M+, 80), 358(33), 327(12), 287(32), 155(100)
6-deoxo-28-norTE 6-deoxo-28-nor-3-DHT 0.615 442(M+, 73), 427(10), 246(12), 231(100), 217(23), 163(20), 141(15)
6-deoxo-28-norTY 0.523 516(M+, 23), 501(6), 459(4), 426(62), 411(60), 305(11), 230(30), 215(100), 141(24)
28-norTE 0.906 530(M+, 21), 515(50), 501(100), 440(5), 316(18), 141(12)
6-deoxo-28-nor-3-DHT 6-deoxo-28-norTE 0.605 516(M+, 73), 501(65), 459(25), 426(23), 411(36), 305(38), 230(26), 215(100), 141(17)
6-deoxo-28-norTY 0.523 516(M+, 21), 501(5), 459(4), 426(60), 411(59), 305(10), 230(32), 215(100), 141(24)
28-nor-3-DHT 0.876 456(M+, 91), 399(3), 316(20), 286(13), 245(33), 141(100)
6-deoxo-28-norTY 6-deoxo-28-nor-3-DHT 0.615 442(M+, 74), 427(10), 246(12), 231(100), 217(22), 163(20), 141(14)
6-deoxo-28-norTE 0.605 516(M+, 71), 501(62), 459(25), 426(23), 411(35), 305(36), 230(26), 215(100), 141(23)
28-norTY 0.735 530(M+, 60), 515(34), 501(100), 440(55), 425(24), 229(15), 141(23)
6-deoxo-28-norCS 0.619 484(M+, 51), 469(16), 288(15), 273(100), 205(24), 141(21)
6-deoxo-28-norCS 28-norCS 0.866 498(M+, 100), 483(3), 399(4), 358(12), 328(7), 287(36), 141(54)
a RRt: relative retention time on GC.
b The sample was analysed as BMB.
c The sample was analysed as BMB-TMSi ether.
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Arabidopsis mutants det2 and dwf4
The restoration of growth in the BR-deﬁcient mutants, det2
and dwf4, was evaluated in dark-grown seedlings via the
application of C27-sterols and C27-BRs.
The det2 mutant was rescued by biosynthetically down-
stream C27-BRs in the early and late C-6 oxidation
pathway, such as 6-deoxo-28-norCT, 6-deoxo-28-norTE,
6-deoxo-28-norTY, 28-norTE, 28-norTY, and 28-norCS,
with more downstream BRs being more biologically active
(Fig. 4A). A similar growth recovery rate was also observed
in the dwf4 mutant (Fig. 4B).
In an effort to investigate the role of the DET2 gene
encoding for steroid 5a-reductase in C27-BRs biosynthesis,
enzyme extracts were prepared from the wild-type Col-
0 and the mutant det2, and were fed on cholesterol. The
conversion of cholesterol to cholestanol was detected in
Col-0 (Fig. 5A) but not in det2 (Fig. 5B), thereby indicating
that the DET2 gene is involved in the conversion of
cholesterol to cholestanol, and hence in the biosynthesis of
C27-BRs.
The DWF4 gene encoding for steroid 22-hydroxylase
was also evaluated for the conversion of cholestanol to
6-deoxo-28-norCT using the enzyme extract prepared from
Fig. 2. Comparison of BR C-6 oxidase activity in CYP85A1/V60/WAT21 and CYP85A2/V60/WAT21 strains. (A) C-6 oxidation for C27-
BRs, (B) C-6 oxidation for C28-BRs.
Fig. 3. Metabolism of 28-norCS in Arabidopsis. 28-NorCS converted to 26,28-didemethyl-CS (tentative), but not to 28-norBL.
Table 3. GC-MS/SIM data for C24-methylation of 28-norTE, 28-
nor-3-DHT, 28-norTY, 28-norCS to TE, 3-DHT, TY, and CS in the
presence of SAM and NADPH
Substrate Metabolite Conversion rate (%)
28-norTE TE 0.2
28-nor-3-DHT 3-DHT 0.2
28-norTY TY 0.3
28-norCS CS 6.0
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extract from En-2 successfully catalysed the conversion of
cholestanol to 6-deoxo-28-norCT (Fig. 5C), but that from
dwf4 did not (Fig. 5D), thereby indicating that the DWF4
gene is involved in the biosynthesis of C27-BRs.
Discussion
It was reported previously that the endogenous level of
28-norCS (0.24 ng g
1 fresh weight) in Arabidopsis reaches
a level approximately one-eighth that of CS (2.01 ng g
1
fresh weight) (Kim et al., 2005b). Furthermore, it has been
demonstrated that a change as small as 20% in the
endogenous level of CS can induce phenotypic alternations,
thereby suggesting that C27-BRs including 28-norCS must
play an important role in the growth and development of
Arabidopsis (Kim et al., 2005b; Kwon et al., 2005). In
seedlings of Arabidopsis, cholesterol, the parent sterol of
28-norCS, is contained at one-third the levels of campes-
terol, the parent sterol of CS (Table 1); this indicates that
Arabidopsis contains a sufﬁcient reservoir of cholesterol for
use in the synthesis of 28-norCS.
Biosynthetic pathway of C27-BRs via late C-6 oxidation
In this study, it has been demonstrated, using Arabidopsis
seedlings, that the synthesis of 28-norCS from cholesterol
occurs via the late C-6 oxidation pathway: choles-
terol/cholestanol/6-deoxo-28-norCT/6-deoxo-28-
norTE46-deoxo-28-nor-3-DHT46-deoxo-28-norTY/6-
deoxo-28-norCS/28-norCS. The same biosynthetic path-
way has been tentatively proposed in the tomato plant
(Yokota et al., 2001).
Recent biochemical studies conducted by Ohnishi et al.
(2006, 2009) have demonstrated that the CYP90B1-
mediated 22-hydroxylation of campesterol is an important
ﬁrst step in the synthesis of C28-BRs in Arabidopsis.
Campesterol and cholesterol were found to be favourable
substrates for this enzyme, when compared with campesta-
nol and cholestanol (Fujita et al., 2006). It is therefore
assumed that the formation of 22-hydroxycholesterol
from cholesterol is an important step in 28-norCS
Fig. 4. Growth recovery of det2 (A) and dwf4 (B) by C27-sterols and C27-BRs. (A) A, Col-0/B-L, det2; B, Control; C, det2+cholesterol;
D, det2+Cholest-4-en-3-one; E, det2+cholestanol; F, det2+6-deoxo-28-norCT; G, det2+6-deoxo-28-norTE; H, det2+6-deoxo-28-norTY;
I, det2+6-oxocholestanol; J, det2+28-norTE; K, det2+28-norTY; L, det2+28-norCS. (B) a, Wild-type (En-2); b, dwf4;c ,dwf4+6-
oxocholestanol; d, dwf4+28-norTE; e, dwf4+28-norTY; f, dwf4+28-norCS. Error bars donate standard errors (n >30).
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the 22-hydroxylation of cholesterol, is currently being
investigated.
The early C-6 oxidation pathway of C27-BRs is blocked
and 6-oxoBRs is derived from respective 6-deoxoBRs
It was determined that the early C-6 oxidation pathway
halted at the stage of 6-oxocholestanol because its presumed
metabolite, 28-norCT, was not generated after incubation
with a microsomal enzyme preparation. In addition, endog-
enous 28-norCT we could not be identiﬁed, even using as
much as 30 kg fresh weight of Arabidopsis plants (data not
shown). However, Arabidopsis contained enzymes that
converted 28-norTE to 28-nor-3-DHT, 28-norTY, and 28-
norCS successively, thereby indicating that the BRs belong-
ing to the early C-6 oxidation pathway are supplied by
respective 6-deoxoBRs. Among the enzymes responsible for
C-6 oxidation of C27-BRs, CYP85A2 was determined to be
15 times as active as CYP85A1 in the C-6 oxidation of C27-
BRs, thereby indicating that CYP85A2 performs a central
function in the C-6 oxidation of C27-BRs (Fig. 2A).
CYP85A2 has been determined to be more powerful than
CYP85A1 in the C-6 oxidation of C28-BRs (Kim et al.,
2005b). CYP85A2 also exhibits BL synthase activity (Kim
et al., 2005b; Kwon et al., 2005; Nomura et al., 2005).
However, CYP85A2 did not catalyse the 7-oxalactonation
of 28-norCS to 28-norBL, thereby suggesting that
CYP85A2 is speciﬁc for the conversion of CS to BL.
Disproof against the early C-6 oxidation pathway of
C28-BRs
Some evidence has accumulated against the notion that
the early C-6 oxidation pathway plays a role in C28-BR
biosyntheses. The ﬁrst step of this pathway is the
6-oxidation of campestanol to 6-oxocampestanol, which
has previously been identiﬁed from Catharanthus crown gall
cells (Fujioka and Sakurai, 1997). However, since that time,
the occurrence of 6-oxocampestanol in other plants has yet
to be conﬁrmed. It has been determined that CYP85A1 and
CYP85A2, which are known as BR 6-oxidases, did not
catalyse this reaction, leaving the responsible enzyme to be
determined (Shimada et al., 2001; Kim et al., 2005b; Kwon
et al., 2005). Furthermore, the 22-hydroxylation of
6-oxocampestanol to CT has yet to be conﬁrmed even in
Fig. 5. GC-SIM analysis conversion of cholesterol to cholestanol and cholestanol to 6-deoxo-28-norCT in det2 (B) and dwf4 (D),
respectively. (A) Conversion of cholesterol to cholestanol in Col-0, the wild type of det2. (C) Conversion of cholestanol to 6-deoxo-28-
norCT in En-2, the wild type of dwf4.
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in the cells (Fujioka et al., 1995). The conversion of
6-oxocampestanol to CT, as well as the presence of CT in
any other plants, has yet to be demonstrated (Fujioka et al.,
1995; Joo et al., 2002). Recently, Fujita et al. (2006)
demonstrated that DWF4 (CYP90B1) 22-hydroxylated
campestanol, but not 6-oxocampestanol. Altogether, our
results indicate that the early C-6 oxidation pathway is
commonly interrupted in plant tissues.
Biosyntheses of C27- and C28-BRs are catalysed by the
same enzymes
Biosynthetic reactions occurring in C27-BRs biosynthesis, in-
cluding 5a-reduction, C-22 hydroxylation, C-23 hydroxylation,
C-3 epimerization, C-2 a-hydroxylation, and C-6 oxidation, are
exactly the same as those occurring in C28-BRs biosynthesis.
This may suggest that the same enzymes mediate the same
reactions in the biosyntheses of both C28-BRs and C27-BRs. In
support of this notion, heterologously-expressed CYP85A1 and
CYP85A2 involved in the C-6 oxidation of C28-BRs exert the
same activity in the biosynthesis of C27-BRs. The det2 mutant
cannot 5a-hydrogenate campesterol, and also cannot
5a-hydrogenate cholesterol (Fig. 5B), whereas the dwf4 mutant
catalyses the 22R-hydroxylation of neither campestanol nor
cholestanol. Moreover, the abnormal growth of det2 and dwf4
mutants was successfully restored via the exogenous application
of downstream C27-BRs. Collectively, the ﬁndings of this study
suggest that C27-BRs and C28-BRs biosynthesis are most likely
controlled by the same biosynthetic enzymes.
CS synthesis from 28-norCS via methylation
It has been determined that Arabidopsis enzyme extract can
methylate 28-norCS to CS. This constitutes a supplement to
our earlier report demonstrating the presence of the same
enzymatic activity in the tomato (Kim et al., 2004b). It
appears that this methylation reaction may be a ubiquitous
event in the plant kingdom. As shown in Fig. 6, using the
tomato plant, it was determined that this reaction occurs via
the following three steps: (i) desaturation of 28-norCS to
form D
24-28-norCS, (ii) SAM-dependent methylation of
D
24-28-norCS to form dolichosterone (DS), and (iii)
NADPH-dependent reduction of DS by NADPH to form
CS (Kim et al., 2004b). The SAM-dependent methylation is
presumed to be catalysed by sterol methyltransferase
1 (SMT1). The NADPH-dependent reduction will be
controlled by the DWF1 gene in Arabidopsis or its orthologue
gene, OsDWF2, in rice. In support of this, the Osdwf2 rice
mutant accumulates DS (Hong et al.,2 0 0 5 ). Additional
evidence was recently obtained, using a P. vulgaris enzyme
extract, that NADPH is required for the conversion of DS to
CS (Joo et al.,2 0 0 9 ). It was found that 28-norCS is far more
readily methylated than 28-norTE and 28-norTY in Arabi-
dopsis, which indicates that C27-BRs and C28-BRs are
connected largely through the passage from 28-norCS to CS
(Fig. 1). In order to conﬁrm the presence of these steps in
Arabidopsis, metabolic and molecular genetic studies using
relevant mutants are currently underway.
Deactivation of 28-norCS through demethylation
28-NorCS fed to the Arabidopsis enzyme extract was not
only methylated, but also demethylated. It has been
demonstrated previously in several plants that CS and BL
are deactivated via C-26 demethylation into 26-norCS and
26-norBL (Kim et al., 2000; 2004a). Therefore, the deme-
thylation product of 28-norCS is tentatively designated as
26,28-norCS. Such demethylation events appear to perform
a crucial role in regulating the levels of 28-norCS, which is
regarded as biologically active per se (Kim et al., 2005a).
Fig. 6. A proposed scheme for the three step C-24 methylation of 28-norCS to CS in the presence of SAM and NADPH in Arabidopsis.
S indicates the same ring structure as that of 28-norCS and CS.
Fig. 7. Biosynthetic connection of C27-BRs (28-norBRs), C28-BRs
(24-methylene BRs and 24-methyl BRs) and C29-BRs (24-ethyl
BRs) in plants. The multiple BRs biosynthetic pathways are
funneled into CS to show BR activity in plant growth and
development.
C27-BRs biosynthesis in A. thaliana | 1831In conclusion, it has been demonstrated here that multiple
biosynthetic pathways lead to CS. Recently, Joo et al. (2009)
determined that, in P. vulgaris, DS is hydrogenated to CS.
Our recent study (unpublished) revealed another biosyn-
thetic pathway from 28-homoCS to CS via C-28 demethyla-
tion. Thus, it is most conceivable that all the biosynthetic
pathways of BRs in plants are funnelled into CS to carry out
the relevant biological activities (Fig. 7).
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